» Articles » PMID: 37291105

Inflammation and Aging: Signaling Pathways and Intervention Therapies

Overview
Date 2023 Jun 8
PMID 37291105
Authors
Affiliations
Soon will be listed here.
Abstract

Aging is characterized by systemic chronic inflammation, which is accompanied by cellular senescence, immunosenescence, organ dysfunction, and age-related diseases. Given the multidimensional complexity of aging, there is an urgent need for a systematic organization of inflammaging through dimensionality reduction. Factors secreted by senescent cells, known as the senescence-associated secretory phenotype (SASP), promote chronic inflammation and can induce senescence in normal cells. At the same time, chronic inflammation accelerates the senescence of immune cells, resulting in weakened immune function and an inability to clear senescent cells and inflammatory factors, which creates a vicious cycle of inflammation and senescence. Persistently elevated inflammation levels in organs such as the bone marrow, liver, and lungs cannot be eliminated in time, leading to organ damage and aging-related diseases. Therefore, inflammation has been recognized as an endogenous factor in aging, and the elimination of inflammation could be a potential strategy for anti-aging. Here we discuss inflammaging at the molecular, cellular, organ, and disease levels, and review current aging models, the implications of cutting-edge single cell technologies, as well as anti-aging strategies. Since preventing and alleviating aging-related diseases and improving the overall quality of life are the ultimate goals of aging research, our review highlights the critical features and potential mechanisms of inflammation and aging, along with the latest developments and future directions in aging research, providing a theoretical foundation for novel and practical anti-aging strategies.

Citing Articles

TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases.

Hui L, Chen X, Huang M, Jiang Y, Liu T Int J Mol Sci. 2025; 26(5).

PMID: 40076567 PMC: 11900955. DOI: 10.3390/ijms26051941.


From Embryogenesis to Senescence: The Role of Mammary Gland Physiology in Breast Cancer Risk.

Lue J, Radisky D Cancers (Basel). 2025; 17(5).

PMID: 40075637 PMC: 11898936. DOI: 10.3390/cancers17050787.


Genetically supported targets and drug repurposing for brain aging: A systematic study in the UK Biobank.

Yi F, Yuan J, Somekh J, Peleg M, Zhu Y, Jia Z Sci Adv. 2025; 11(11):eadr3757.

PMID: 40073132 PMC: 11900869. DOI: 10.1126/sciadv.adr3757.


Protective effects of Rosa roxburghii Tratt. extract against UVB-induced inflammaging through inhibiting the IL-17 pathway.

Zhang S, Chen Y, Qu L Sci Rep. 2025; 15(1):8260.

PMID: 40064976 PMC: 11893735. DOI: 10.1038/s41598-025-92559-8.


Perianal fistulizing Crohn's disease: Mechanisms and treatment options focusing on cellular therapy.

Bhatnagar P, Elhariri S, Burud I, Eid N World J Gastroenterol. 2025; 31(9):100221.

PMID: 40061590 PMC: 11886048. DOI: 10.3748/wjg.v31.i9.100221.


References
1.
Soukas A, Hao H, Wu L . Metformin as Anti-Aging Therapy: Is It for Everyone?. Trends Endocrinol Metab. 2019; 30(10):745-755. PMC: 6779524. DOI: 10.1016/j.tem.2019.07.015. View

2.
Banoth B, Tuladhar S, Karki R, Sharma B, Briard B, Kesavardhana S . ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). J Biol Chem. 2020; 295(52):18276-18283. PMC: 7939383. DOI: 10.1074/jbc.RA120.015924. View

3.
Ding H, Chen S, Pan X, Dai X, Pan G, Li Z . Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis. J Cachexia Sarcopenia Muscle. 2021; 12(3):746-768. PMC: 8200440. DOI: 10.1002/jcsm.12700. View

4.
Li G, Yu M, Lee W, Tsang M, Krishnan E, Weyand C . Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med. 2012; 18(10):1518-24. PMC: 3466346. DOI: 10.1038/nm.2963. View

5.
Nogueira-Recalde U, Lorenzo-Gomez I, Blanco F, Loza M, Grassi D, Shirinsky V . Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine. 2019; 45:588-605. PMC: 6642320. DOI: 10.1016/j.ebiom.2019.06.049. View